Answers are grounded in this paper and cite their sources.
Lung squamous cell carcinoma (LUSC) lacks effective targeted therapies due to limited understanding of tumor-microenvironment crosstalk. We investigated whether Methyltransferase Like 7 B (METTL7B) is associated with LUSC progression through regulation of SPP1 and signaling interactions between tumor cells and M2-like macrophages. Bioinformatic analysis of GEO and UALCAN datasets identified Secreted Phosphoprotein 1 (SPP1) overexpression, which was then examined in an exploratory cohort of 36 LUSC clinical specimens. SRAMP was used to predict potential m 6 A sites in the SPP1 transcript, and RIP, MeRIP, and actinomycin D assays were used to examine the association of METTL7B with SPP1 mRNA binding, m 6 A enrichment, and mRNA stability. We knocked down SPP1 in LUSC cells to assess proliferation, migration/invasion and epithelial-mesenchymal transition. Cancer cell-macrophage crosstalk was evaluated by co-culturing SPP1-knockdown LUSC cells with THP-1-derived macrophages to assess M2 polarization, TGF-β1 secretion and functional consequences on angiogenesis and tumor growth. Public datasets showed SPP1 overexpression associated with poor prognosis, and exploratory analysis of 36 LUSC specimens showed SPP1 expression correlated with M2 macrophage markers. METTL7B knockdown reduced m 6 A enrichment on SPP1 transcripts and shortened SPP1 mRNA half-life, suggesting that METTL7B is involved in maintaining SPP1 mRNA stability, possibly through an m 6 A-related mechanism that requires further validation. SPP1 knockdown suppressed proliferation, migration, invasion, and EMT in vitro. SPP1 knockdown in LUSC cells reduced M2-like markers (CD206/CD163) and TGF-β1 expression in co-cultured THP-1-derived macrophages, and macrophage-conditioned medium enhanced SMAD3 phosphorylation in cancer cells in a TGF-β1-dependent manner. In vitro, neutralizing TGF-β1 or knocking down SPP1 reduced angiogenesis and malignant phenotypes of LUSC cells; in a xenograft model, SPP1 knockdown reduced tumor growth and intratumoral M2-like macrophage infiltration. METTL7B may contribute to SPP1 mRNA stability, potentially through an m 6 A-related mechanism, and SPP1 may in turn support an SPP1/TGF-β1 signaling circuit between cancer cells and M2-like macrophages that contributes to LUSC progression in the models studied. METTL7B-SPP1-TGF-β1 Axis Is Associated with Progression of Lung Squamous Cell Carcinoma. METTL7B is associated with SPP1 expression and mRNA stability in lung squamous cell carcinoma, possibly through an m 6 A-related mechanism that requires further validation. SPP1 is associated with M2-like macrophage polarization and TGF-β1 secretion, which in turn activates SMAD3 signaling in cancer cells to enhance proliferation, migration, invasion, EMT, and angiogenesis in vitro. This METTL7B/SPP1/TGF-β1 signaling axis may sustain a pro-tumor microenvironment.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: